Table Of Contents
Cancer Risks Most Associated With Belviq
Belviq was recalled following the FDA’s review of the CAMELLIA-TIMI 61 clinical trial , which found more cancer diagnoses among Belviq users compared to patients who took a placebo. Imbalances in specific cancers including pancreatic cancer, colorectal cancer, and lung cancer contributed to the observed overall imbalance in cancer cases identified by the study, according to the FDA.
Although these were the most common cancers, they were not the only types. Patients received a variety of cancer diagnoses over the course of the 5-year trial.
Related Article: Belviq (Lorcaserin) Lawsuit Update
How Does Belviq Work?
Belviq works to control appetite by activating serotonin receptors in the brain. Serotonin is a neurotransmitter that triggers feelings of well-being such as satisfaction, gratification, and being fully fed.
Most patients take regular versions of Belviq tablets twice per day. Extended-release tablets are taken only once per day. Belviq users are supposed to lose 5% of their body weight during the first 12 weeks of initiating treatment when used in conjunction with exercise and a healthy diet.
What are the Side Effects of Belviq?
In addition to being linked to an increased risk for cancer, Belviq has been linked to other, more moderate side effects including:
- Dry mouth
Talk to your doctor immediately if you have any of these side effects after taking Belviq.
Related Article: Why was Belviq Taken Off the Market?
Are Lawsuits Being Filed Against Belviq Manufacturers?
Victims of cancer are currently in the process of filing lawsuits against Eisai Inc., the manufacturer of Belviq, stating that using the medication led to their illness. These actions bring several accusations against the company, including the failure to conduct proper research of Belviq and Belviq XR side effects before releasing the drug, failure to publicly acknowledge the link between Belviq and cancer, and the intentional postponement of recalling it from the U.S. market.
Related Article: Should You File a Belviq Lawsuit?
What To Do if You Got Cancer After Taking Belviq
If you or a loved one was diagnosed with cancer after taking Belviq, you may be entitled to financial compensation for your injuries. Since the FDA released data from the CAMELLIA-TIMI 61 clinical trial, patients have started filing lawsuits against Eisai Inc.
Don’t wait to take action if you’ve been harmed. If you have cancer and took Belviq, contact the experienced defective drugs lawyers at Schmidt & Clark, LLP, today. Although lung cancer, pancreatic cancer, and colorectal cancer were most common in the study, any cancer diagnosis could qualify.
See the other dangerous drug lawsuits we’ve taken on.
Get a Free Lawsuit Evaluation With Our Lawyers
The Pharmaceutical Litigation Group at Schmidt & Clark, LLP law firm is an experienced team of trial lawyers that focus on the representation of plaintiffs in lawsuits. We are handling individual litigation nationwide and currently accepting new injury and death cases in all 50 states.
If you or a loved one got cancer after taking Belviq, you should contact our law firm immediately. You may be entitled to a settlement by filing a suit and we can help.